Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
824
datasets available to search
ShareScore release 0.9.0
Dataset results
824 results for “doxorubicin”
TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT03387917. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
ClinicalTrials.gov study NCT00410462. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis
ClinicalTrials.gov study NCT02475772. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis.
ClinicalTrials.gov study NCT04077905. IPD Sharing: NO. Countries: 1. Publications: 1.
Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast Cancer
ClinicalTrials.gov study NCT00994968. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
ClinicalTrials.gov study NCT00720174. IPD Sharing: Not stated. Countries: 1. Publications: 1.
END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin
ClinicalTrials.gov study NCT00401635. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00306813. IPD Sharing: Not stated. Countries: 1. Publications: 1.
MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer
ClinicalTrials.gov study NCT00326456. IPD Sharing: Not stated. Countries: 3. Publications: 3.
Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)
ClinicalTrials.gov study NCT05377905. IPD Sharing: NO. Countries: 1. Publications: 7.
The Efficacy and Safety of Pegylated Liposomal Doxorubicin Compared With Capecitabine as First Line Chemotherapy for Metastatic Breast Cancer (P04445/MK-2746-071)
ClinicalTrials.gov study NCT00266799. IPD Sharing: YES. Countries: 0. Publications: 1.
Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer.
ClinicalTrials.gov study NCT05271318. IPD Sharing: NO. Countries: 2. Publications: 4.
Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT00886028. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After
ClinicalTrials.gov study NCT00001339. IPD Sharing: Not stated. Countries: 1. Publications: 3.
S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
ClinicalTrials.gov study NCT00016406. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients
ClinicalTrials.gov study NCT00471965. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00005991. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer
ClinicalTrials.gov study NCT00096291. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)
ClinicalTrials.gov study NCT00635193. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer
ClinicalTrials.gov study NCT00793377. IPD Sharing: Not stated. Countries: 1. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.